Finch Therapeutics Group (FNCH) News Today $11.09 +0.05 (+0.45%) (As of 09:35 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 Time Period August 18, 2024 | americanbankingnews.comFinch Therapeutics Group (NASDAQ:FNCH) Stock Price Up 7.7%August 10, 2024 | reuters.comFinch wins US jury trial against Ferring over fecal-transplant patentsApril 17, 2024 | marketbeat.comTrading was temporarily halted for "FNCH" at 09:04 AM with a stated reason of "LULD pause."April 14, 2024 | fool.comFinch Therapeutics Group (NASDAQ: FNCH)March 31, 2024 | insidertrades.comJeffery A. Smisek Sells 6,642 Shares of Finch Therapeutics Group, Inc. (NASDAQ:FNCH) StockMarch 25, 2024 | investorplace.comFNCH Stock Earnings: Finch Therapeutics Gr Reported Results for Q4 2023March 7, 2024 | investing.comFinch Therapeutics Group Inc (FNCH)February 22, 2024 | benzinga.comFinch Therapeutics Gr Stock (NASDAQ:FNCH), Short Interest ReportDecember 1, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 03:12 PM with a stated reason of "LULD pause." Trading set to resume at 03:12 PM. December 1, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 09:12 AM with a stated reason of "LULD pause."November 5, 2023 | morningstar.comFinch Therapeutics Group Inc FNCHOctober 18, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 09:10 AM with a stated reason of "LULD pause."August 21, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Nuvation Bio (NUVB), Finch Therapeutics Group (FNCH)June 12, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 03:06 PM with a stated reason of "LULD pause."June 12, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 03:06 PM with a stated reason of "LULD pause."June 12, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 02:06 PM with a stated reason of "LULD pause."June 9, 2023 | finanznachrichten.deFinch Therapeutics Group, Inc.: Finch Announces Reverse Stock Split of Common StockMay 13, 2023 | msn.comHC Wainwright & Co. Reiterates Finch Therapeutics Group (FNCH) Buy RecommendationMay 12, 2023 | marketwatch.com8-K: Finch Therapeutics Group, Inc.May 10, 2023 | finanznachrichten.deFinch Therapeutics Group, Inc.: Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesMay 10, 2023 | finance.yahoo.comFinch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesApril 25, 2023 | finance.yahoo.comFinch Therapeutics Announces Executive Leadership TransitionsApril 22, 2023 | finanznachrichten.deFINCH THERAPEUTICS GROUP INCApril 18, 2023 | finance.yahoo.comFinch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License AgreementApril 4, 2023 | markets.businessinsider.comFinch Therapeutics Group (FNCH) Gets a Buy from H.C. WainwrightApril 3, 2023 | finanznachrichten.deFinch Therapeutics Group, Inc.: Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesMarch 25, 2023 | msn.comLooking Into Finch Therapeutics Group's Return On Capital EmployedMarch 25, 2023 | finance.yahoo.comFinch Therapeutics Group Full Year 2022 Earnings: Misses ExpectationsMarch 23, 2023 | finance.yahoo.comFinch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesJanuary 24, 2023 | finance.yahoo.comMicrobiome startup cuts 95% of remaining staff in 3rd layoff in 9 monthsJanuary 24, 2023 | marketwatch.comFinch Therapeutics Ending Phase 3 Study, Cutting Most of Workforce >FNCHJanuary 24, 2023 | finance.yahoo.comFinch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other AssetsJanuary 24, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 07:01 AM with a stated reason of "News pending."November 11, 2022 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Kezar Life Sciences (KZR), RVL Pharmaceuticals (RVLP)November 11, 2022 | finance.yahoo.comFinch Therapeutics Provides Corporate Updates and Reports Third Quarter 2022 Financial ResultsNovember 9, 2022 | finance.yahoo.comFinch Therapeutics to Present at the Jefferies London Healthcare Conference and Evercore ISI HealthCONx ConferenceOctober 24, 2022 | finance.yahoo.comFinch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022 and Proceeds with Patient Dosing in Phase 3 Trial of CP101 in Recurrent C. Difficile InfectionOctober 1, 2022 | seekingalpha.comFNCH Finch Therapeutics Group, Inc.September 1, 2022 | finance.yahoo.comAfter Takeda ends collaboration, microbiome startup Finch Therapeutics cuts 50 jobsSeptember 1, 2022 | markets.businessinsider.comFinch Therapeutics To Reduce Workforce - Quick FactsSeptember 1, 2022 | finance.yahoo.comFinch Therapeutics Provides Business UpdateAugust 29, 2022 | marketbeat.comFinch Therapeutics Group, Inc. (NASDAQ:FNCH) Short Interest Down 19.6% in AugustFinch Therapeutics Group, Inc. (NASDAQ:FNCH - Get Rating) was the target of a significant decrease in short interest in August. As of August 15th, there was short interest totalling 231,400 shares, a decrease of 19.6% from the July 31st total of 287,700 shares. Approximately 1.5% of the company's stock are short sold. Based on an average trading volume of 82,400 shares, the short-interest ratio is currently 2.8 days.August 11, 2022 | finance.yahoo.comFinch Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial ResultsAugust 10, 2022 | finance.yahoo.comHere's Why We're Watching Finch Therapeutics Group's (NASDAQ:FNCH) Cash Burn SituationJuly 20, 2022 | nasdaq.comAs Finch Therapeutics Group, Inc.'s market cap (NASDAQ:FNCH) drops to US$103m, insiders might be questioning their decision to buy earlier this yearJuly 20, 2022 | finance.yahoo.comAs Finch Therapeutics Group, Inc. (NASDAQ:FNCH) drops to US$103m market cap, insiders might rethink their US$650k stock purchase earlier this yearJune 2, 2022 | finance.yahoo.comFinch Therapeutics to Participate in Upcoming June Investor ConferencesMay 16, 2022 | finance.yahoo.comFinch Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial ResultsMay 9, 2022 | finance.yahoo.comFinch Therapeutics to Host Corporate Update Conference Call and Webcast on May 16, 2022May 2, 2022 | nz.finance.yahoo.comFinch Therapeutics Group, Inc. (FNCH) Get Finch Therapeutics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for FNCH and its competitors with MarketBeat's FREE daily newsletter. Email Address 3 dividend stocks to own (Ad)The “Income Ace” Jack Carter just revealed his entire dividend strategy. Including 3 specific tickers to consider owning. And his “golden rules” for trading dividend stocks. These aren’t just theoretical rules, either. Jack revealed that the vast majority of his income capital is deployed in this straightforward portfolio of dividend stocks. Watch this presentation asap. FNCH Media Mentions By Week FNCH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FNCH News Sentiment▼0.820.44▲Average Medical News Sentiment FNCH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FNCH Articles This Week▼10▲FNCH Articles Average Week Get Finch Therapeutics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for FNCH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRIS News ALGS News GRTS News PMVP News BNTC News IKNA News OMGA News IFRX News OVID News CKPT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FNCH) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Finch Therapeutics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Finch Therapeutics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
